The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index; 37 of the 67 sources its claims cite were checked for support.
Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species
Open accessAbstract
Fluconazole (FLC) is extensively employed for the prophylaxis and treatment of invasive fungal infections (IFIs). However, the fungistatic nature of FLC renders pathogenic fungi capable of developing tolerance towards it. Consequently, converting FLC into a fungicidal agent using adjuvants assumes significance to circumvent FLC resistance and the perpetuation of fungal infections. This drug repurposing study has successfully identified pitavastatin calcium (PIT) as a promising adjuvant for enhancing the fungicidal activity of FLC from a comprehensive library of 2372 FDA-approved drugs. PIT could render FLC fungicidal even at concentrations as low as 1 μM. The median lethal dose (LD50) of PIT was determined to be 103.6 mg/kg. We have discovered that PIT achieves its synergistic effect by inhibiting the activity of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, thereby impeding ubiquinone biosynthesis, inducing reactive oxygen species (ROS) generation, triggering apoptosis, and disrupting Golgi function. We employed a Candida albicans strain that demonstrated a notable tolerance to FLC to infect mice and found that PIT effectively augmented the antifungal efficacy of FLC against IFIs. This study is an illustrative example of how FDA-approved drugs can effectively eliminate fungal tolerance to FLC.
Overview
CoChat Summary
TL;DR
A screen of 2372 FDA-approved drugs identified pitavastatin calcium (PIT) as a fluconazole (FLC) adjuvant that converts FLC from fungistatic to fungicidal at low concentrations. PIT acts by inhibiting HMG-CoA reductase/ubiquinone biosynthesis, increasing ROS and apoptosis, disrupting Golgi function, and improving outcomes in mice infected with highly FLC-tolerant Candida albicans.
Key findings
- From 2372 FDA-approved drugs, 222 prevented C. albicans recovery with 4 μg/mL FLC; after excluding 22 known antifungals, 200 were tested, 30 made FLC fungicidal below 12.5 μM, and 12 did so at ≤3.125 μM with FLC ≤4 μg/mL. Eight compounds cleared FLC tolerance in disk diffusion assays across four strains.
- PIT had an LD50 of 103.6 mg/kg, compared with 19 mg/kg for GdA and 42 mg/kg for CsA. With 1 μM PIT, FLC MIC decreased from 1 to 0.5 μg/mL and MFC decreased from not detected up to 64 μg/mL to 2 μg/mL, giving MFC/MIC = 4. PIT also rendered voriconazole, ketoconazole, itraconazole, and miconazole fungicidal.
- PIT targeted HMG-CoA reductase/Hmg1: HMG1/hmg1Δ, ERG8/erg8Δ, and IDI1/idi1Δ mutants were more susceptible to 4 μM PIT; HMG1 overexpression and exogenous mevalonate mitigated PIT. PIT + FLC increased intracellular and mitochondrial ROS about 2-fold, upregulated MCA1 about 7-fold vs control and 2.5-fold vs FLC alone, upregulated CYC3 about 15.7-fold vs control and 4.3-fold vs FLC alone, and increased caspase activity nearly 2-fold vs FLC alone. Ergosterol plus ubiquinone together reversed the synergistic lethality.
- In mice infected with high FLC-tolerant cmp1-aidΔ/cmp1-aidΔ, FLC 1 mg/kg + PIT 0.5 mg/kg reduced kidney fungal burden (p = 0.0032 at day 6; p = 0.0023 at day 10). With clinical isolate 283, FLC 4 mg/kg + PIT 1 or 3 mg/kg reduced kidney burden (p = 0.0192 and p = 0.0054). Mortality over 30 days was 60% in controls, 50% with FLC alone, and 10% with FLC + PIT 3 mg/kg (p = 0.0204 vs control; p = 0.0477 vs FLC).
Methods
- High-throughput screen of 2372 FDA-approved drugs at 100 μM with 4 μg/mL FLC against C. albicans SC5314, followed by broth microdilution, dose–matrix titration, disk diffusion, spotting, MFC determination, qRT-PCR, gene deletion/overexpression, ROS measurement, caspase assay, and membrane permeability assays.
- Acute toxicity was assessed by the OECD 425 Up-and-Down procedure via intraperitoneal administration in mice to determine LD50.
- Murine invasive candidiasis used female C57BL/6 mice (6–8 weeks old, 17–19 g) infected by tail vein with C. albicans strains or clinical isolate 283; FLC ± PIT was given intraperitoneally for 3 days, with survival monitored for 30 days, fungal burden measured in spleen/liver/kidney, and histopathology performed. Statistical analyses included two-tailed unpaired t-tests, Kaplan–Meier curves, and log-rank tests.
Limitations
- Stated in the paper: “this study did not directly measure intracellular ergosterol levels,” although ergosterol-synthesis inhibition was supported by mevalonate rescue and gene-expression data.
- Evident from the text: the in vivo work is limited to mouse models, with fungal-burden analyses using six mice per group and survival analyses using ten mice per group; no human clinical data are reported.
- Evident from the text: the mechanism is inferred largely from genetic susceptibility, overexpression, and metabolite-rescue experiments; direct enzymatic measurement of Hmg1 activity or direct quantification of ubiquinone levels is not reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
23 Valid · 3 Not valid · 7 Not checked · 95 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Augmenting intracellular ROS levels in C. albicans offers a promising strategy for achieving fungicidal outcomes, like applying amphotericin B and miconazole, ultimately leading to cell demise [55].”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 3. Results > 3.6. The Combination of PIT and FLC Elicits Reactive Oxygen Species (ROS) Generation by Inhibiting Ubiquinone Production
What the sources say
- Supportedcites [55] Belenky, 2013, Fungicidal drugs induce a common oxidative-damage cellular death pathway, Cell Rep. source
The Introduction (page not provided) states that amphotericin B and miconazole induce a pathway in C. albicans that culminates in lethal ROS formation. The Results section, “Fungicide-Dependent ROS Production Leads to Fungal Cell Death” (page not provided), reports ROS induction after fungicidal treatment and identifies ROS as critical to drug-induced death. This supports the claim’s hedged description of a promising fungicidal strategy. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These observations suggested that PIT targets HMG-CoA reductase encoded by the HMG1 (C1_03780C_A) gene in C. albicans [50].”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 3. Results > 3.5. PIT Makes FLC Fungicidal Depending on Targeting HMG-CoA Reductase
What the sources say
- Partly supportedcites [50] Callegari, 2010, Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation, FEMS Yeast Res. sourceExperimental — accuracy not yet measured
The Introduction (page not provided) identifies HMG-CoA reductase as the molecular target of statins, and the sterol-synthesis results section links atorvastatin toxicity to its inhibition in S. cerevisiae. The paper does not establish that PIT targets the enzyme in C. albicans or identify its HMG1 gene (C1_03780C_A). (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is imperative to render FLC fungicidal to effectively manage IFIs, as an increase in FLC tolerance leads to FLC resistance [10] and persistent candidemia [11,12].”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 1. Introduction
What the sources say
- Partly supportedcites [11] Rosenberg, 2018, Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia, Nat. Commun. sourceExperimental — accuracy not yet measured
In the section “Persistent candidemia is associated with highly tolerant isolates,” isolates from persistent infections had higher FLC tolerance than isolates from infections cleared by treatment. The paper describes a correlation; it does not establish that an increase in tolerance causes persistent candidemia. Page numbers are not available in the supplied passages. (LLM, conf=0.88)
- Partly supportedcites [12] Levinson, 2021, Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection, Mycoses sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that fluconazole tolerance was associated with failure to eradicate bloodstream Candida infections in patients, which supports a link to persistent candidemia. The Discussion (page unavailable) reports that tolerance predicted treatment failure in patients treated within 24 hours, but the paper does not establish that increasing tolerance causes persistent candidemia. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nevertheless, the fungistatic nature of FLC renders pathogenic fungi capable of developing tolerance, characterized by FLC-susceptible fungal strains surviving at FLC concentrations higher than the minimum inhibitory concentration (MIC) [9].”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 1. Introduction
What the sources say
- Partly supportedcites [9] Berman, 2020, Drug resistance and tolerance in fungi, Nat. Rev. Microbiol. sourceExperimental — accuracy not yet measured
The Introduction defines tolerance as growth of drug-susceptible fungal strains above the MIC, and says antifungal tolerance is most evident with fungistatic drugs. The paper discusses fluconazole-tolerant cells, but does not establish that fluconazole’s fungistatic nature itself causes pathogenic fungi to develop tolerance. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although certain adjuvants, such as CsA and GdA, can make FLC fungicidal in laboratory studies, their clinical applications are limited due to their high toxicity [43,44].”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 3. Results > 3.3. PIT Has Low Toxicity
What the sources say
- Not checked — no full text of the sourcecites [43] Patocka, 2021, Cyclosporine A: Chemistry and Toxicity—A Review, Curr. Med. Chem. source
- Partly supportedcites [44] Sanchez, 2020, Old and New Approaches to Target the Hsp90 Chaperone, Curr. Cancer Drug Targets sourceExperimental — accuracy not yet measured
The “Natural Products and their Derivatives” section says GdA is a poor clinical candidate partly because of in vivo toxicity. It does not establish the same limitation for CsA; the passages found concern Hsp90 inhibitors in cancer, not the clinical use of either agent with fluconazole. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
79 more claims · 5 with their cited sources checked
Create a free account to see all 128 claims and every source verdict.
- It may state two separate claims as one. 32
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the cmp1-aidΔ/cmp1-aidΔ mutant, with the C-terminal 110 residues of Cmp1 deleted, exhibits high FLC tolerance51”
From Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities (2025) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 2. Materials and Methods > 2.13. Murine Invasive C. albicans Infections
“along with intraperitoneal administration of PIT at doses of 1 or 3 mg/kg once a day for three consecutive days.”
§ Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species > 3. Results > 3.8. PIT Enhances the Antifungal Efficacy of FLC against Invasive Candidiasis Caused by High FLC-Tolerant C. albicans Strains
“FLC (1 mg/kg) + PIT (0.5 mg/kg) significantly reduced the fungal burden in the kidney”
Citations
Cites
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718 · cited 2×
“…(atorvastatin hydrochloride, cerivastatin sodium, cilastatin Here, we systematically evaluated the synergetic lethal , atorvastatin hemicalcium, bestatin, bestatin hydrochloride , fl uvastatin sodium, lovastatin, pentostatin, PIT, especially identifying advantages of pharmacokinetic drug [67].”
BackgroundDrug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237 · cited 2×
“FDA-approved drugs [66].”
BackgroundOxidative stress and cancer: Have we moved forward?
Halliwell, B. (2007) · Biochemical Journal · doi:10.1042/bj20061131 · Cited by 1,302 · cited 1×
“This oxidation process can lead to compromised functionality of these essential biological macromolecules, ultimately causing damage to the membrane and triggering programmed cell death in the fungal pathogen [60,61].”
BackgroundThe global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 4×
“It is imperative to render FLC fungicidal to effectively manage IFIs, as an increase in FLC tolerance leads to FLC resistance [10] and persistent candidemia [11,12].”
BackgroundInfluentialDrug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642 · cited 2×
“Nevertheless, the fungistatic nature of FLC renders pathogenic fungi capable of developing tolerance, characterized by FLC-susceptible fungal strains surviving at FLC concentrations higher than the minimum inhibitory concentration (MIC) [9].”
BackgroundNoble, S. M., & Johnson, A. D. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.2.298-309.2005 · Cited by 592 · cited 1×
“Target gene null mutants were constructed using fusion PCR to obtain homologous recombinant sequences, as previously described [30].”
MethodCombination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541 · cited 1×
“These studies commonly employed the fractional inhibitory concentration index (FICI) to assess the synergy between FLC and existing drugs, with a FICI value of ≤ 0.5 indicating synergy [22].”
MethodInfluentialApoptosis induced by environmental stresses and amphotericin B in Candida albicans
Phillips, A. J., Sudbery, I., & Ramsdale, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332326100 · Cited by 398 · cited 1×
“This oxidation process can lead to compromised functionality of these essential biological macromolecules, ultimately causing damage to the membrane and triggering programmed cell death in the fungal pathogen [60,61].”
Background
Cited by
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Self-citationFang, T., Xiong, J., Huang, X., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127964 · Cited by 17
Self-citationShi, Q., Yang, R., Yang, J., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202422669 · Cited by 12
Li, W., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-62131-z · Cited by 13
“Consequently, the cmp1 - aid Δ / cmp1 - aid Δ mutant, with the C-terminal 110 residues of Cmp1 deleted, exhibits high FLC tolerance 51 .”
Self-citationChai, X., Jiang, Y., Lu, H. J., & Huang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574990 · Cited by 9
Self-citation
Metadata
- Authors
- Li, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y.
- Affiliations
- Tongji University (CN)
- Concordia University (CA)
- Corresponding author
- Lu, Hui
- Jiang, Yuanying
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2024-05-29
- Volume
- 13
- Issue
- 6
- Pages
- 667
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC11200976
- OpenAlex
- W4399217048
- Cited by
- 14
- References
- 80
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 1
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Key Research and Development Program of China (2022YFC2303004, 2021YFC2300404, 82020108032, 202101070007-E00094)
- National Natural Science Foundation of China (2022YFC2303004, 2021YFC2300404, 82020108032, 202101070007-E00094)
- Innovation Program of Shanghai Municipal Education Commission (2022YFC2303004, 2021YFC2300404, 82020108032, 202101070007-E00094)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- fluconazole, drug repurposing, fungicidal activity, drug synergy, HMG-CoA reductase inhibition, ubiquinone biosynthesis, reactive oxygen species, apoptosis, Golgi function, Candida albicans, invasive fungal infections, antifungal resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species. https://app.cochat.ai/papers/10.3390/antiox13060667
- The paper
- Li, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y. (2024). Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species. Antioxidants. https://doi.org/10.3390/antiox13060667
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.